Sourcing an ivd antibody for a diagnostic product: what separates a research reagent from one a manufacturer can build a device around, what to ask an antibody manufacturer about change control and lot reservation, and the documentation a supplier has to provide

What a diagnostic manufacturer has to establish

1. Establish the grade and what it commits the supplier to. Research use only material carries no commitment to consistency or notification. A reagent sold for diagnostic manufacture should come with a specification, a certificate per lot against it, and a stated change control process. Ask what the grade actually obliges the supplier to do.
2. Get change notification in the contract. A supplier changing a purification step, a host cell line or a buffer without telling you can invalidate a validated assay silently. Notification before change, with enough lead time to bridge, is the single most valuable term in the agreement.
3. Reserve a lot and bridge between lots. Reserve enough of one lot to cover production and validation, and run a bridging study when moving lots, comparing performance in the actual assay rather than on a binding measurement. Lot change is the commonest cause of a diagnostic assay drifting.
4. Collect the documentation your quality system needs. Specification, certificate of analysis per lot, animal origin and source material statements, a supplier quality agreement and audit rights. Supplier controls are a regulated requirement for a device manufacturer, not paperwork for its own sake.
5. Assess supply risk as seriously as performance. A single source reagent with no second supplier is a single point of failure for the product. Ask about capacity, about how long the supplier commits to producing it, and what notice of discontinuation you would receive.

Qualifying the reagent in your own assay

Performance in the device is the qualification that counts: sensitivity, specificity, the effect of the matrix and stability in the formulation. A supplier's binding data is an input and never a substitute.

Define acceptance criteria for an incoming lot in your own assay before the first lot change, so a bridging study has something to pass or fail rather than a judgement made under time pressure.

Second sourcing, and why it is hard here

A second antibody is a different molecule and qualifying it is a second validation, so a true second source is expensive. Many manufacturers instead secure supply by reserving inventory and by contractual commitments.

Where the volume justifies it, licensing the sequence and having the antibody produced recombinantly under your own control removes the single point of failure entirely. It is a larger project and it is the durable answer.

Animal origin and source material

Bovine and other animal derived components in the reagent or its formulation carry their own documentation requirements and can restrict markets. Ask for the statements at the point of selection rather than during a submission.

Where an animal free option exists at equivalent performance, it usually simplifies the regulatory path enough to be worth the switch, provided it is made before validation rather than after.

Common questions

What makes an ivd antibody different from a research antibody?

Commitments rather than chemistry: a written specification, a certificate per lot, change notification, lot reservation and documentation your quality system can use. The same clone can be sold at both grades with very different obligations attached.

Can I use a research use only antibody in a diagnostic product?

The labelling restricts the supplier's claim, and the obligation to qualify what goes into a device is the manufacturer's. In practice a reagent with no specification, no change control and no lot certificate is very difficult to qualify and to keep qualified.

Why is change notification so important?

Because an undisclosed process change can shift assay performance without anything visibly failing. Notification with lead time is what lets you bridge lots deliberately instead of discovering a shift in production.

What documentation should a supplier provide?

A product specification, a certificate of analysis per lot against it, source and animal origin statements, and a quality agreement covering change notification and audit rights. Ask for a sample set before committing.

Browse by service class

• Compare Gene synthesis on advertised prices